Clinical Research
临床研究
基本信息
- 批准号:7332204
- 负责人:
- 金额:$ 20.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Antineoplastic ProtocolsBackBreastBudgetsCancer CenterCancer Center Support GrantCancer PatientCaringChargeChemopreventionChestClinicClinicalClinical InvestigatorClinical OncologyClinical ResearchClinical Research ProtocolsClinical TrialsClinical Trials Data Monitoring CommitteesClinical Trials[{..}] Cancer TreatmentConsent FormsDataData CollectionDatabasesDetectionDiagnosisDiagnostic radiologic examinationDisciplineDiscipline of NursingDisorder by SiteDoctor of MedicineEligibility DeterminationEnsureFundingGenitourinary systemGynecologic OncologyHematologyHospitalsIndividualLaboratoriesLeadershipMalignant NeoplasmsMedical FacultyMedical OncologyMonitorMonitoring Clinical TrialsNewly DiagnosedNorris Cotton Cancer CenterNursing FacultyOncology GroupOperative Surgical ProceduresPalliative CarePalliative Care NursingPathologyPatient CarePatientsPediatric OncologyPeer ReviewPharmacistsPharmacy facilityPhysiciansPoliciesProcessProtocols documentationRadiation OncologyRecordsRegistered nurseRegistriesReportingResearchResearch Ethics CommitteesResearch SupportResource SharingResourcesSafetyScreening procedureServicesSiteStagingStandards of Weights and MeasuresSurgical OncologySystemTranslational ResearchWorkWritinganticancer researchbasecancer carecancer research center directorcancer sitecooperative studygastrointestinalmedical schoolsmelanomamembermultidisciplinaryneuro-oncologyoncologypatient oriented researchprofessorprogramstumor
项目摘要
The Clinical Research Office Shared Resource (CRO) oversees the review, initiation, conduct, and safety monitoring of clinical trials at the Norris Cotton Cancer Center. The CRO components are 1) an administrative staff including the Shared Resource Director, an Associate Director, an Assistant Director, a financial manager, and a protocol assistant; 2) the Protocol-Specific Research Support staff, comprising a research pharmacist, a pharmacy technician, two research registered nurses, and 16 clinical research assistants / coordinators; 3) the Protocol Review and Monitoring System, consisting of the Clinical Cancer Research Committee (CCRC) and the Safety and Data Monitoring Committee (SDMC); and 4) the Dartmouth-Hitchcock Tumor Registry, staffed by three registrars. Although DHMC and the NCCC have designated the CRO as the office responsible for administrative oversight of all aspects of clinical cancer research including the hospital tumor registry, our request for CCSG funding is for the more narrowly
defined functions of this Shared Resource related to support peer-reviewed clinical trials of cancer treatment and chemoprevention. The CRO maintains local Dartmouth Medical School studies, working group studies, cooperative group protocols, and industrial trials. It is responsible for assisting in formatting protocols, writing consent forms, maintaining Institutional Review Board and SDMC records, developing budgets, assessing impact on institutional resources, activating protocols, assessing eligibility, developing data collection forms and
databases, and collecting and managing data. Prioritization of clinical trials is determined within the 12 NCCC Clinical Oncology Groups, with approval by the CCRC. The CRO acts as a checkpoint prior to activation of protocols to ensure that all appropriate administrative aspects of trials are complete. Charge-back policies of the CRO accurately reflect usage, and are based on patient accrual to reviewed and approved protocols.
临床研究办公室共享资源 (CRO) 负责监督 Norris Cotton 癌症中心临床试验的审查、启动、实施和安全监测。 CRO 的组成部分包括: 1) 行政人员,包括共享资源总监、副总监、助理总监、财务经理和礼宾助理; 2) 方案特定研究支持人员,包括一名研究药剂师、一名药房技术员、两名研究注册护士和 16 名临床研究助理/协调员; 3)方案审查和监测系统,由临床癌症研究委员会(CCRC)和安全与数据监测委员会(SDMC)组成; 4) 达特茅斯-希区柯克肿瘤登记处,由三名登记员组成。尽管 DHMC 和 NCCC 已指定 CRO 为办公室,负责对临床癌症研究的各个方面(包括医院肿瘤登记处)进行行政监督,但我们对 CCSG 资金的请求是针对更狭隘的领域。
该共享资源的定义功能与支持癌症治疗和化学预防的同行评审临床试验有关。 CRO 维护当地达特茅斯医学院的研究、工作组研究、合作组协议和工业试验。它负责协助格式化协议、撰写同意书、维护机构审查委员会和 SDMC 记录、制定预算、评估对机构资源的影响、激活协议、评估资格、制定数据收集表格和
数据库,以及收集和管理数据。临床试验的优先顺序由 12 个 NCCC 临床肿瘤学小组确定,并经 CCRC 批准。 CRO 充当协议激活之前的检查点,以确保试验的所有适当管理方面均已完成。 CRO 的退款政策准确反映了使用情况,并基于患者对经审查和批准的方案的应计情况。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAYMOND P PEREZ其他文献
RAYMOND P PEREZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAYMOND P PEREZ', 18)}}的其他基金
Inhibition of S14 by Conjugated Linoleic Acid in Advanced Solid Tumor Patients
共轭亚油酸对晚期实体瘤患者中 S14 的抑制作用
- 批准号:
7738712 - 财政年份:2009
- 资助金额:
$ 20.54万 - 项目类别:
SPRY2 predicts survival post-chemotherapy in advanced ovarian cancer.
SPRY2 预测晚期卵巢癌化疗后的生存率。
- 批准号:
8402675 - 财政年份:2009
- 资助金额:
$ 20.54万 - 项目类别:
Inhibition of S14 by Conjugated Linoleic Acid in Advanced Solid Tumor Patients
共轭亚油酸对晚期实体瘤患者中 S14 的抑制作用
- 批准号:
7915780 - 财政年份:2009
- 资助金额:
$ 20.54万 - 项目类别:
SPRY2 predicts survival post-chemotherapy in advanced ovarian cancer.
SPRY2 预测晚期卵巢癌化疗后的生存率。
- 批准号:
7707876 - 财政年份:2009
- 资助金额:
$ 20.54万 - 项目类别:
Atorvastatin, a prenylation inhibitor in acute leukemia.
阿托伐他汀,一种治疗急性白血病的异戊二烯化抑制剂。
- 批准号:
6488366 - 财政年份:2002
- 资助金额:
$ 20.54万 - 项目类别:
Atorvastatin, a prenylation inhibitor in acute leukemia.
阿托伐他汀,一种治疗急性白血病的异戊二烯化抑制剂。
- 批准号:
6626312 - 财政年份:2002
- 资助金额:
$ 20.54万 - 项目类别:
MODULATION OF CLINICAL SENSITIVITY TO CHEMOTHERAPY
调节临床对化疗的敏感性
- 批准号:
6514257 - 财政年份:2000
- 资助金额:
$ 20.54万 - 项目类别:
相似国自然基金
基于Teach-back药学科普模式的慢阻肺患者吸入用药依从性及疗效研究
- 批准号:2024KP61
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Quench-Back保护的超导螺线管磁体失超过程数值模拟研究
- 批准号:51307073
- 批准年份:2013
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
CAREER: From Dynamic Algorithms to Fast Optimization and Back
职业:从动态算法到快速优化并返回
- 批准号:
2338816 - 财政年份:2024
- 资助金额:
$ 20.54万 - 项目类别:
Continuing Grant
One-step reconstruction of plastic waste back to its constituent monomers (ONESTEP)
将塑料废物一步重建回其组成单体(ONESTEP)
- 批准号:
EP/Y003934/1 - 财政年份:2024
- 资助金额:
$ 20.54万 - 项目类别:
Research Grant
On the origin of very massive back holes
关于巨大背洞的起源
- 批准号:
DP240101786 - 财政年份:2024
- 资助金额:
$ 20.54万 - 项目类别:
Discovery Projects
Back to our roots: Re-activating Indigenous biocultural conservation
回到我们的根源:重新激活本土生物文化保护
- 批准号:
FT230100595 - 财政年份:2024
- 资助金额:
$ 20.54万 - 项目类别:
ARC Future Fellowships
Collaborative Research: FuSe: Indium selenides based back end of line neuromorphic accelerators
合作研究:FuSe:基于硒化铟的后端神经形态加速器
- 批准号:
2328741 - 财政年份:2023
- 资助金额:
$ 20.54万 - 项目类别:
Continuing Grant
Collaborative Research: NSFGEO-NERC: MEZCAL: Methods for Extending the horiZontal Coverage of the Amoc Latitudinally and back in time (MEZCAL)
合作研究:NSFGEO-NERC:MEZCAL:扩展 Amoc 纬度和时间回水平覆盖范围的方法 (MEZCAL)
- 批准号:
2409764 - 财政年份:2023
- 资助金额:
$ 20.54万 - 项目类别:
Standard Grant
Relationships Between Pain-Related Psychological Factors, Gait Quality, and Attention in Chronic Low Back Pain
慢性腰痛中疼痛相关心理因素、步态质量和注意力之间的关系
- 批准号:
10679189 - 财政年份:2023
- 资助金额:
$ 20.54万 - 项目类别:
The Role of VEGF in the Development of Low Back Pain Following IVD Injury
VEGF 在 IVD 损伤后腰痛发展中的作用
- 批准号:
10668079 - 财政年份:2023
- 资助金额:
$ 20.54万 - 项目类别:
Psilocybin and Affective Function in Chronic Lower Back Pain and Depression
裸盖菇素与慢性腰痛和抑郁症的情感功能
- 批准号:
10626449 - 财政年份:2023
- 资助金额:
$ 20.54万 - 项目类别:
Brain Mechanisms of Chronic Low-Back Pain: Specificity and Effects of Aging and Sex
慢性腰痛的脑机制:衰老和性别的特异性和影响
- 批准号:
10657958 - 财政年份:2023
- 资助金额:
$ 20.54万 - 项目类别: